Jen Herbach

Peep this legend Jen Herbach – she’s the real deal in biotech, no cap. So, she’s a YC W23 alum, which already shows she’s got that hustle and credibility. But what really gets me is her process. She’s been deep in the biotech game for over a decade, grinding at places like Amunix, InterMune, and Onyx Pharmaceuticals. Like, she’s been in the trenches, bringing crazy new oncology drugs to life. That’s not some overnight success – that’s years of blood, sweat, and tears building stuff that actually matters.

Now, she’s the CEO and Co-Founder of Adventris Pharmaceuticals. These guys are all about cancer vaccines, especially targeting those stubborn KRAS mutations – the ones that mess with a ton of cancer treatments. Basically, she’s jumping into the hardest, most complex problems out there, trying to crack the code on cancer immunotherapy. And she’s not doing it alone – she leads a team of top-tier researchers and works with some of the biggest names in immuno-oncology. That’s some advanced collaboration, showing she’s got the vision and the network to make shit happen.

What’s crazy is she’s got an MBA from Harvard Business School – so she’s not just a scientist, she’s got that business and strategy game on lock. She understands how to build a company, guide market access, and price drugs right. That combo of science and business? That’s what it takes to turn biotech dreams into reality.

She’s based in San Francisco, but her startup’s HQ is in Baltimore – shows she’s got that cross-country hustle. It’s like she’s got her eye on the big picture, always pushing forward, always thinking bigger.

Bottom line: Jen’s story is about someone who’s been through the trenches, who’s seen what works and what doesn’t, and now she’s using all that experience to fight cancer in a totally new way. She’s not just building a company – she’s on a mission to change lives, and she’s crushing it. That’s why she’s a total big change in biotech.